查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1552456

全球止血劑（止血材料）市場：到2033年的機會與策略

Hemostats Global Market Opportunities And Strategies To 2033
出版日期: | 出版商: The Business Research Company | 英文 285 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2018年全球止血劑（hemostat）市值為27.8087億美元，直到2023年複合年成長率超過2.0%。

手術次數增加

外科手術的增加帶動了業績期間內止血劑（止血材料）市場的成長。止血劑產品對於心血管外科、整形外科、神經外科和一般外科等不同外科專業至關重要，對整體市場需求做出了重大貢獻。各種外科手術的增加直接導致醫療保健環境中對止血劑（止血劑）的需求增加。例如，2022 年 2 月美國臉部整形與重建外科學會 (AAFPRS) 的一份報告發現，2021 年進行了 140 萬個例外科和非外科手術，比 2020 年平均增加了 600 例。因此，外科手術的增加支持了止血劑（止血劑）市場的成長。

目錄

第1章執行摘要

  • 止血劑（止血材料）-市場吸引力與宏觀經濟情勢

第2章 目錄

第3章表格一覽

第4章圖表一覽

第5章 報告結構

第6章市場特點

  • 一般市場定義
  • 概述
  • 止血劑（止血材料）市場定義及細分
  • 市場區隔：按產品
    • 活性止血劑（止血材料）
    • 被動止血劑（止血材料）
    • 複方止血劑（止血材料）
    • 其他產品
  • 市場區隔：依格式
    • 基質型和凝膠型止血劑（止血材料）
    • 床單、墊片用止血劑（止血材料）
    • 海綿止血劑（止血材料）
    • 粉末止血劑
    • 其他形式
  • 市場區隔：按應用
    • 整形外科
    • 一般外科
    • 神經外科
    • 心血管外科
    • 重組手術
    • 婦科手術
    • 其他用途

第7章 主要市場趨勢

  • 止血粉技術創新
  • 市場參與者之間的策略合作與夥伴關係
  • 針對困難出血情況的尖端止血解決方案

第8章止血劑市場：宏觀經濟情景

  • COVID-19的影響：止血劑（止血材料）市場
  • 烏克蘭戰爭的影響：止血劑（止血劑）市場
  • 高通膨影響：止血劑（止血劑）市場

第9章世界市場規模與成長

  • 市場規模
  • 2018-2023 年市場成長表現
    • 2018-2023年市場促進因素
    • 2018-2023年市場限制因素
  • 市場成長預測，2023-2028，2033F
    • 2023-2028年市場促進因素
    • 2023-2028年市場限制因素

第10章 全球止血劑（止血材料）市場：細分

  • 全球止血劑（止血材料）市場：依產品分類的表現與預測，2018-2023、2028F、2033F
  • 全球止血劑（止血劑）市場：依處方分類的表現與預測，2018-2023、2028F、2033F
  • 全球止血劑（止血材料）市場：按應用分類的表現和預測，2018-2023、2028F、2033F

第11章止血劑（止血材料）市場：區域與國家分析

  • 全球止血劑（止血劑）市場：按地區分類的績效與預測，2018-2023、2028F、2033F
  • 全球止血劑（止血材料）市場：依國家分類的表現與預測，2018-2023、2028F、2033F

第12章亞太市場

第13章西歐市場

第14章 東歐市場

第15章 北美市場

第16章 南美洲市場

第17章 中東市場

第18章 非洲市場

第19章 競爭格局及公司概況

  • 公司簡介
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Integra LifeSciences Corporation
  • Johnson & Johnson
  • Stryker Corporation

第20章 競爭基準化分析

第 21 章競爭對手儀表板

第22章 重大併購

  • AA Medical Acquired Surgical Product Solutions（SPS）
  • Hemostasis LLC Acquired Fiagon Medical Technologies
  • Ethicon Acquired GATT Technologies BV
  • Baxter Acquired CryoLife
  • Teleflex Acquired Z-Medica

第23章機遇與策略

  • 2028 年全球止血劑市場：提供新機會的國家
  • 2028 年全球止血劑市場：提供新機會的細分市場
  • 2028年全球止血劑（止血材料）市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第24章 止血劑（止血材料）市場：結論與建議

  • 結論
  • 推薦
    • 產品
    • 地方
    • 價格
    • 晉升
    • 人們

第25章附錄

簡介目錄
Product Code: o&s1313

Hemostats are surgical devices used to control bleeding during surgical procedures, making them essential in the medical and healthcare industry. These devices work by promoting blood clotting at the site of a surgical incision, thereby preventing excessive blood loss and facilitating the healing process.

The hemostats market consists of sales, by entities (organizations, sole traders and partnerships), of hemostats tools or equipment that are utilized by surgeons and medical practitioners across a wide range of surgical fields, including but not limited to orthopedic, neurological, cardiovascular, reconstructive, gynecological and general surgeries, to reduce or suppress bleeding. They are often used in operating rooms, emergency rooms and other medical settings where bleeding control is critical.

The global hemostats market was valued at $2,780.87 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 2.0%.

Increase In Surgical Procedures

An increase in surgical procedures drove the growth of the hemostats market during the historic period. Hemostatic products are essential across diverse surgical specialties such as cardiovascular, orthopedic, neurosurgery and general surgery, contributing significantly to the overall market demand. The growth in these varied surgical procedures directly drives the increasing need for hemostats in healthcare settings. For instance, according to the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) report in February 2022, 1.4 million surgical and non-surgical procedures were done in 2021, on an average of 600 more procedures had increased when compared with 2020. Therefore, an increase in surgical procedures supported the growth of the hemostats market.

Innovation In Hemostatic Powder Technology

Major companies operating in the hemostats market are focused on advancing their new technologies and research and developments. New product lines ensure that surgeons have access to the right tools for effectively controlling bleeding across a wide range of surgical procedures, thereby optimizing patient care. For instance, in March 2023, Baxter, a US-based healthcare company, launched PERCLOT Absorbable Hemostatic Powder in the U.S. PERCLOT is a passive, absorbable hemostatic powder that is ready-to-use and designed for patients with intact coagulation to address mild bleeding. The launch of PERCLOT in the U.S. provides surgeons a full range of active and passive hemostatic products for bleeding control, helping to optimize care for their patients.

The global hemostats market is highly concentrated, with a few large players operating in the market. The top ten competitors in the market made up to 60.22% of the total market in 2023.

Hemostats Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global hemostats market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for hemostats? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The hemostats market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider hemostats market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by formulation and by application.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the hemostats market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by product, by formulation and by application in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for hemostats providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Product: Active Hemostats; Passive Hemostats; Combination Hemostats; Other Products
  • 2) By Formulation: Matrix And Gel Hemostats; Sheet And Pad Hemostats; Sponge Hemostats; Powder Hemostats; Other Formulations
  • 3) By Application: Orthopedic Surgery; General Surgery; Neurological Surgery; Cardiovascular Surgery; Reconstructive Surgery; Gynecological Surgery; Other Applications
  • Companies Mentioned: Baxter International Inc.; B. Braun Melsungen AG; Integra LifeSciences Corporation; Johnson & Johnson Inc.; Stryker Corporation
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; hemostats indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Hemostats - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Hemostats Market Definition And Segmentations
  • 6.4 Market Segmentation By Product
    • 6.4.1 Active Hemostats
    • 6.4.2 Passive Hemostats
    • 6.4.3 Combination Hemostats
    • 6.4.4 Other Products
  • 6.5 Market Segmentation By Formulation
    • 6.5.1 Matrix And Gel Hemostats
    • 6.5.2 Sheet And Pad Hemostats
    • 6.5.3 Sponge Hemostats
    • 6.5.4 Powder Hemostats
    • 6.5.5 Other Formulations
  • 6.6 Market Segmentation By Application
    • 6.6.1 Orthopedic Surgery
    • 6.6.2 General Surgery
    • 6.6.3 Neurological Surgery
    • 6.6.4 Cardiovascular Surgery
    • 6.6.5 Reconstructive Surgery
    • 6.6.6 Gynecological Surgery
    • 6.6.7 Other Applications

7 Major Market Trends

  • 7.1 Innovation In Hemostatic Powder Technology
  • 7.2 Strategic Collaborations And Partnerships Among Market Players
  • 7.3 Cutting-Edge Hemostat Solutions For Challenging Bleeding Scenarios

8 Hemostats Market - Macro Economic Scenario

  • 8.1 COVID-19 Impact On The Hemostats Market
  • 8.2 Impact Of The War In Ukraine On The Hemostats Market
  • 8.3 Impact Of High Inflation On The Hemostats Market

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Hemostats Market Segmentation

  • 10.1 Global Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Hemostats Market, Regional and Country Analysis

  • 11.1 Global Hemostats Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Hemostats Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Regulatory Bodies
    • 12.2.7 Major Associations
    • 12.2.8 Taxes Levied
    • 12.2.9 Corporate Tax Structure
    • 12.2.10 Investments
    • 12.2.11 Major Companies
  • 12.3 Asia-Pacific Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.6 Asia-Pacific Hemostats Market: Country Analysis
  • 12.7 China Market
  • 12.8 Summary
  • 12.9 Market Overview
    • 12.9.1 Country Information
    • 12.9.2 Market Information
    • 12.9.3 Background Information
    • 12.9.4 Government Initiatives
    • 12.9.5 Regulations
    • 12.9.6 Regulatory Bodies
    • 12.9.7 Major Associations
    • 12.9.8 Taxes Levied
    • 12.9.9 Corporate Tax Structure
    • 12.9.10 Major Companies
  • 12.10 China Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 China Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.12 China Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Market
  • 12.14 India Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 India Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.16 India Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Market
  • 12.18 Japan Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Japan Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.20 Japan Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Market
  • 12.22 Australia Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Australia Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.24 Australia Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Market
  • 12.26 Indonesia Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 Indonesia Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.28 Indonesia Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Market
  • 12.30 South Korea Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.31 South Korea Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.32 South Korea Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate Tax Structure
    • 13.2.10 Investments
    • 13.2.11 Major Companies
  • 13.3 Western Europe Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.6 Western Europe Hemostats Market: Country Analysis
  • 13.7 UK Market
  • 13.8 UK Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 UK Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.11 Germany Market
  • 13.12 Germany Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 Germany Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.15 France Market
  • 13.16 France Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 France Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.19 Italy Market
  • 13.20 Italy Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Italy Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.23 Spain Market
  • 13.24 Spain Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.26 Spain Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate Tax Structure
    • 14.2.10 Major Companies
  • 14.3 Eastern Europe Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.6 Eastern Europe Hemostats Market: Country Analysis
  • 14.7 Russia Market
  • 14.8 Russia Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.10 Russia Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulations
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Investments
    • 15.2.11 Major Companies
  • 15.3 North America Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.6 North America Hemostats Market: Country Analysis
  • 15.7 USA Market
  • 15.8 Summary
  • 15.9 Market Overview
    • 15.9.1 Country Information
    • 15.9.2 Market Information
    • 15.9.3 Background Information
    • 15.9.4 Government Initiatives
    • 15.9.5 Regulations
    • 15.9.6 Regulatory Bodies
    • 15.9.7 Major Associations
    • 15.9.8 Taxes Levied
    • 15.9.9 Corporate Tax Structure
    • 15.9.10 Investments
    • 15.9.11 Major Companies
  • 15.10 USA Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 USA Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.12 USA Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Market
  • 15.14 Canada Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.15 Canada Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.16 Canada Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Regulations
    • 16.2.5 Regulatory Bodies
    • 16.2.6 Major Associations
    • 16.2.7 Taxes Levied
    • 16.2.8 Corporate Tax Structure
    • 16.2.9 Major Companies
  • 16.3 South America Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.6 South America Hemostats Market: Country Analysis
  • 16.7 Brazil Market
  • 16.8 Brazil Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.10 Brazil Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Investments
    • 17.2.11 Major Companies
  • 17.3 Middle East Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.5 Middle East Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
  • 18.2 Market Overview
    • 18.2.1 Region Information
    • 18.2.2 Market Information
    • 18.2.3 Background Information
    • 18.2.4 Government Initiatives
    • 18.2.5 Regulations
    • 18.2.6 Regulatory Bodies
    • 18.2.7 Major Associations
    • 18.2.8 Taxes Levied
    • 18.2.9 Corporate Tax Structure
    • 18.2.10 Investments
    • 18.2.11 Major Companies
  • 18.3 Africa Hemostats Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Hemostats Market, Segmentation By Formulation, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.5 Africa Hemostats Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 Baxter International Inc.
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial Overview
  • 19.3 B. Braun Melsungen AG
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.4 Integra LifeSciences Corporation
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 Johnson & Johnson
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview
  • 19.6 Stryker Corporation
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Financial Overview

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 AA Medical Acquired Surgical Product Solutions (SPS)
  • 22.2 Hemostasis LLC Acquired Fiagon Medical Technologies
  • 22.3 Ethicon Acquired GATT Technologies B.V
  • 22.4 Baxter Acquired CryoLife
  • 22.5 Teleflex Acquired Z-Medica

23 Opportunities And Strategies

  • 23.1 Global Hemostats Market In 2028 - Countries Offering Most New Opportunities
  • 23.2 Global Hemostats Market In 2028 - Segments Offering Most New Opportunities
  • 23.3 Global Hemostats Market In 2028 - Growth Strategies
    • 23.3.1 Market Trend Based Strategies
    • 23.3.2 Competitor Strategies

24 Hemostats Market, Conclusions And Recommendations

  • 24.1 Conclusions
  • 24.2 Recommendations
    • 24.2.1 Product
    • 24.2.2 Place
    • 24.2.3 Price
    • 24.2.4 Promotion
    • 24.2.5 People

25 Appendix

  • 25.1 Geographies Covered
  • 25.2 Market Data Sources
  • 25.3 Research Methodology
  • 25.4 Currencies
  • 25.5 The Business Research Company
  • 25.6 Copyright and Disclaimer